• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2025 Jul 22;80(Supplement_1):S29-S36.
doi: 10.1093/cid/ciaf056. Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria

Elizabeth T Akande[SUP] 1 [/SUP], Adeola A Fowotade[SUP] 2 3 [/SUP], Erkison Ewomazino Odih[SUP] 1 [/SUP], Anderson O Oaikhena[SUP] 1 [/SUP], Olasunkanmi Olisa[SUP] 2 [/SUP], Gabriel Temitope Sunmonu[SUP] 1 [/SUP], Boluwatife Adebiyi[SUP] 1 [/SUP], Olabisi C Akinlabi[SUP] 1 [/SUP], Oluwafemi A Popoola[SUP] 3 4 [/SUP], Temitope O Alonge[SUP] 3 [/SUP], Iruka N Okeke[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Oyo State, Nigeria, reported its first coronavirus disease 2019 (COVID-19) case on 21 March 2020 and subsequently recorded the fifth highest number of cases in Nigeria, most in the capital city Ibadan. We aimed to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that were circulating in Ibadan between August 2021 and August 2022 and to assess the utility of healthcare worker (HCW)-associated infections for endemic COVID-19 surveillance.
Methods: Following ethical approval, SARS-CoV-2 real-time quantitative polymerase chain reaction (RT-qPCR)-confirmed samples were reverse-transcribed and sequenced on an Illumina MiSeq using ARTIC SARS-CoV-2 RT-PCR and sequencing protocols. Genomes were assembled using the nf-core/viralrecon pipeline. Quality control, phylogenetic, analysis, and variant identification were performed using publicly available software implemented in a custom Nextflow pipeline. Biodata and relevant clinical information were obtained from electronic case investigation forms.
Results: We analyzed 258 samples with minimum non-N coverage of 70% and identified 12 SARS-CoV-2 lineages and 7 clades, all but one aligning with global lineages. Lineages BA.1 (22%) and BA.1.1 (48%) were the most common. Delta lineage predominated from August to September 2021, and was replaced by Omicron lineage from December 2021. Samples from HCWs (n = 60; 23%) accounted for a third (4 of 12) of all major lineages observed.
Conclusions: We contributed 258 genomes from Oyo State to the GSAID repository and identified Delta and Omicron lineages circulating in Ibadan, in temporal alignment with global circulating lineages. As clinical testing declines HCWs are useful sentinels for genomic epidemiology capturing much of the diversity.

Keywords: COVID-19; Delta variant; Ibadan; Nigeria; Omicron variant; SARS-CoV-2; healthcare worker.

 
Back
Top Bottom